Tieling Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tieling Zhou has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Ansam Sinjab
Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
24 shared publications - Fuduan Peng
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA
24 shared publications - Humam Kadara
The University of Texas MD Anderson Cancer Center
24 shared publications - Linghua Wang
Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
24 shared publications - Ashish Damania
Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA
23 shared publications - Boris Sepesi
Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
23 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary figure S1. Effects of fecal microbiota transfer from Lcn2-deficient mice in various mouse models.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary figure S1. Effects of fecal microbiota transfer from Lcn2-deficient mice in various mouse models.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer
Supplementary data, tables and legends
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer
Supplementary data, tables and legends
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Differentially expressed genes in the myeloid cluster of the colonic lamina propria.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Differentially expressed genes in the myeloid cluster of the colonic lamina propria.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Differentially expressed genes in the tumor microenvironment.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Differentially expressed genes in the tumor microenvironment.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary figure S2. scRNA-seq of the colonic lamina propria in the syngeneic mice following FMT.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary figure S2. scRNA-seq of the colonic lamina propria in the syngeneic mice following FMT.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Table S1 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Table S1 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Comparative analysis of microbial abundance in murine fecal samples across FMT groups.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Comparative analysis of microbial abundance in murine fecal samples across FMT groups.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary Figure S4. Immune changes within the TME induced by inflammation related to gut microbiome alterations.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary Figure S4. Immune changes within the TME induced by inflammation related to gut microbiome alterations.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary figure S5. Different species belonging to the genus Alistipes promote the development of LUAD.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary figure S5. Different species belonging to the genus Alistipes promote the development of LUAD.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
LEfSe analysis of differential abundance across groups.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
LEfSe analysis of differential abundance across groups.